Oncogenic Viruses, Volume 1: Fundamentals of Oncoviruses, 2023, Pages 5-27
Hepatocellular carcinoma (HCC) accounts for between 85% and 90% of primary liver cancers. It has several interesting epidemiological characteristics. Differences in distribution have been noted between geographic regions and ethnic groups but also according to sex and the presence of several risk factors linked to the environment. A variety of risk factors for HCC have been reported, including hepatitis B and C viruses, aflatoxin B1, alcohol consumption, nonalcoholic fatty liver disease, and hemochromatosis. Hepatitis B virus (HBV) is a ubiquitous virus with worldwide distribution.
Oncogenic Viruses
Volume 1: Fundamentals of Oncoviruses
2023, Pages 243-262
Biodegradability of Conventional Plastics: Opportunities, Challenges, and Misconceptions, Volume 1, 1 January 2022
Biodegradability of Conventional Plastics: Opportunities, Challenges, and Misconceptions, Volume 1, 1 January 2022
Current Developments in Biotechnology and Bioengineering: Microplastics and Nanoplastics: Occurrence, Environmental Impacts and Treatment Processes, 2023, Pages 387-403
Oncogenic Viruses, Volume 2: Medical Applications of Viral Oncology Research 2023, Pages 173-189
Hepatitis B virus (HBV) is a hepatotropic virus capable of evading immune defense, usually leading to chronic hepatitis and hepatocellular carcinoma. The death rate in case of patients suffering from liver cancer associated with hepatitis B oncovirus is on the rise. Thus to effectively reduce the incidence of this disease, vaccination with preventive HBV vaccines is essential, and continuous development of therapeutic vaccines is needed to treat patients with preexisting infection.
